Free Motion to Amend/Correct - District Court of Delaware - Delaware

Case 1:08-cv-00339-SLR

Document 15

Filed 08/19/2008

Page 1 of 3

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE TAKEDA PHARMACEUTICAL COMPANY ) ) LIMITED and TAP PHARMACEUTICAL PRODUCTS INC., ) ) ) Plaintiffs, ) ) v. ) BARR PHARMACEUTICALS, INC. and ) BARR LABORATORIES, INC., ) ) Defendants. )

C.A. No. 08-339 (SLR)

TAP'S UNOPPOSED MOTION TO CHANGE THE CAPTION Plaintiff TAP Pharmaceutical Products Inc. ("TAP") moves to substitute Takeda Pharmaceuticals North America, Inc. ("TPNA") as plaintiff in place of TAP. Effective July 1, 2008, current plaintiff TAP merged with TPNA, a corporation duly organized under the laws of the State of Delaware, with its principal place of business in Deerfield, Illinois. As a result of this merger, TAP ceased to exist as an independent corporate entity, and TPNA became its successor-in-interest. Thus, TPNA is now the owner of NDA No. 21-428, and substitution of TPNA for TAP would be appropriate. In addition, TAP seeks to add two new parties -- Takeda Pharmaceuticals LLC ("LLC") and Takeda Pharmaceuticals America, Inc. ("TPA") -- a limited liability company and corporation, respectively, duly organized under the laws of the State of Delaware and wholly owned subsidiaries of TPNA. LLC is now the exclusive licensee to U.S. Patent No. 6,328,994 and the exclusive sublicensee for lansoprazole to U.S. Patent No. 5,464,632, which are the patents-in-suit in this action. TPA holds the exclusive right to sell Prevacid ODT to the public. TPNA holds exclusive rights to import Prevacid ODT and to sell exclusively to LLC. Thus, their joinder as plaintiffs would also be appropriate.

Case 1:08-cv-00339-SLR

Document 15

Filed 08/19/2008

Page 2 of 3

Counsel for all parties have discussed this motion, and Barr will not oppose it. Barr specifically reserves its right to challenge the standing for any of the plaintiffs in this action. MORRIS, NICHOLS, ARSHT & TUNNELL LLP

/s/ Rodger D. Smith II
OF COUNSEL: Eric J. Lobenfeld Tedd W. Van Buskirk Arlene L. Chow Dillon Kim HOGAN & HARTSON LLP 875 Third Avenue New York, NY 10022 (212) 918-3000 Phillipe Y. Reisen HOGAN & HARTSON LLP Shinjuku Center Building, 46th Floor 25-1 Nishi-Shinjuku 1-chome Shinjuku, Tokyo 163-0646 Japan (81) 3-5908-4070 Attorneys for Plaintiff Takeda Pharmaceutical Company, Ltd. William F. Cavanaugh Stuart E. Pollack Patrick S. Almonrode PATTERSON BELKNAP WEBB & TYLER LLP 1133 Avenue of the Americas New York, NY 10036 (212) 336-2000 Attorneys for Takeda Pharmaceuticals North America, Inc., Takeda Pharmaceuticals America, Inc., and Takeda Pharmaceuticals LLC August 19, 2008 Jack B. Blumenfeld (#1014) Mary B. Graham (#2256) Rodger D. Smith (#3778) James W. Parrett, Jr. (#4292) 1201 N. Market Street P.O. Box 1347 Wilmington, DE 19899-1347 (302) 658-9200 [email protected] [email protected] [email protected] [email protected] Attorneys for Takeda Pharmaceutical Company Limited and TAP Pharmaceutical Products Inc.

Case 1:08-cv-00339-SLR

Document 15

Filed 08/19/2008

Page 3 of 3

CERTIFICATE OF SERVICE I hereby certify that on August 19, 2008, I caused the foregoing to be electronically filed with the Clerk of the Court using CM/ECF, which will send electronic notification of such filing to the following: Richard L. Horwitz, Esq. POTTER ANDERSON & CORROON LLP [email protected] Additionally, I hereby certify that true and correct copies of the foregoing were caused to be served on August 19, 2008, upon the following individuals in the manner indicated: BY E-MAIL AND HAND DELIVERY Richard L. Horwitz, Esq. David E. Moore, Esq. POTTER ANDERSON & CORROON LLP Hercules Plaza 6th Floor 1313 N. Market Street P.O. Box 951 Wilmington, DE 19899 [email protected] [email protected] BY E-MAIL Thomas J. Meloro, Esq. Michael W. Johnson, Esq. Colman B. Ragan, Esq. Kathryn M. Fugina, Esq. WILLKIE FARR & GALLAGHER LLP 787 Seventh Avenue New York, NY 10019-3099 [email protected] [email protected] [email protected] [email protected]

/s/ Rodger D. Smith II
______________________________________ Rodger D. Smith II (#3778)

Case 1:08-cv-00339-SLR

Document 15-2

Filed 08/19/2008

Page 1 of 1

IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE TAKEDA PHARMACEUTICAL COMPANY ) ) LIMITED and TAP PHARMACEUTICAL PRODUCTS INC., ) ) ) Plaintiffs, ) ) v. ) BARR PHARMACEUTICALS, INC. and ) BARR LABORATORIES, INC., ) ) Defendants. )

C.A. No. 08-339 (SLR)

PROPOSED ORDER Pursuant to Federal Rules of Civil Procedure 20(a)(1)(A), 25(c), and 41(a), the Court hereby orders that the caption of this action be changed to read as follows: IN THE UNITED STATES DISTRICT COURT FOR THE DISTRICT OF DELAWARE TAKEDA PHARMACEUTICAL COMPANY LIMITED, TAKEDA PHARMACEUTICALS NORTH AMERICA, INC. TAKEDA PHARMACEUTICALS LLC, and TAKEDA PHARMACEUTICALS AMERICA, INC. Plaintiffs, v. BARR PHARMACEUTICALS, INC. and BARR LABORATORIES, INC., Defendants. SO ORDERED Dated:_______________ ________________________________ Honorable Sue L. Robinson United States District Judge ) ) ) ) ) ) ) ) ) ) ) ) )

C.A. No. 08-339-SLR